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Background: N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-
isoxazole-4-propinoic acid (AMPA) receptors bound to postsynaptic density-95
(PSD-95) and a isoform of calcium/calmodulin-dependent protein kinase II
(aCaMKII) is fundamentally involved in the regulation of working memory. The
aim of present study was to investigate the alterations of NMDA and AMPA
receptors responsible for hippocampal synaptic dysfunction and selective neuronal
cell death after chronic renal failure (CRF) which may be associated with impair-
ment of working memory.
Methods: Altered interactions between NMDA and AMPA receptors and PSD-95
and aCaMKII were analyzed in the cornu ammonis (CA) 1 and CA3/dentate gyrus
(DG) subﬁelds of the uremic rat hippocampi using the immunoblotting and
immunoprecipitation methods.
Results: Uremia induced by CRF produced necrotic cell death and decreased
neuronal nucleoli protein levels in the hippocampal CA1 subﬁeld, but not in the
CA3/DG subﬁelds. The CA1 subﬁelds of CRF rats exhibited signiﬁcant decreases
and increases, respectively, in the expressions of PSD-95/NR2B and aCaMKII/
NR2A synaptic complex. Moreover, increased phosphorylation of glutamate
receptor type 1 (GluR1) AMPA receptor at ser831 was observed in the CA1
subﬁeld after CRF.
Conclusion: These hippocampal CA1 neuronal vulnerability may be responsible
for memory dysfunction after CRF as mediated by an increase in NR2A-
containing NMDA receptors bound to aCaMKII and subsequent activation of
GluR1-containing AMPA receptors caused by the phosphorylation of GluR1 at
ser831.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n Society of Nephrology. Published by Elsevier. This is an open access article under the CC BY-NC-ND
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Figure 1. Diagram of the excision remnant kidney model. Experi-
mental chronic renal failure (CRF) was induced by two-stage excision of
about two-thirds of the left kidney and right total nephrectomy. The left
kidney was exposed using a left ﬂank incision and gently dissected free
from the adrenal gland; approximately two-thirds of the left kidney
including the upper and lower pole was excised. One week later, the
right kidney was removed via a right ﬂank incision after dissecting it
free from the adrenal gland. Rats were maintained in metabolic cages
on the days marked with an asterisk. As controls, some rats were
subjected to a sham operation identical to that described above but
without kidney tissue removal.
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In science, cognition is the mental processing that includes
the attention of working memory, comprehending and produ-
cing language, calculating, reasoning, problem solving, and
decision making [1]. The hippocampus belongs to the limbic
system and plays important roles in the consolidation of
spatial working memory. Moreover, hippocampal volume can
be used to detect cognitive dysfunction and identify elderly
people at risk of Alzheimer's disease [2]. However, the selec-
tive vulnerability of hippocampal neurons in chronic renal
failure (CRF) remains speculative even though the hippocam-
pus seems particularly susceptible to a variety of uremic toxins
and metabolites [3]. Clinical studies have demonstrated a high
risk for dementia and cognitive impairment in patients with
chronic kidney disease (CKD) and those undergoing hemo-
dialysis [4,5]. Even in patients with neurologically asympto-
matic chronic renal disease, impaired cognitive processing
can be disclosed by event-related potentials [4]. In animal
studies, evidence indicates that uremia impairs synaptic
transmission in the rat hippocampus, and that this results
in increased glutamate release presynaptically, which in
turn, impairs spontaneous synaptic activity [6]. These obser-
vations suggest that marked elevations in uremic toxin
levels functionally perturb synaptic function of the hippo-
campus and leads to neuronal cell death and subsequent
cognitive dysfunction.
N-methyl-D-aspartate (NMDA) receptors mediate long-
term potentiation which is a candidate mechanism for mem-
ory [7], and play critical roles in synaptic dysfunction and
neuronal cell death [8]. In the hippocampus, the NMDA
receptors are composed of NR1 and NR2 subunits (NR2A,
NR2B), which cluster with scaffolding proteins, such as, post-
synaptic density-95 (PSD-95) and α isoform of calcium/calmo-
dulin-dependent protein kinase II (αCaMKII) [9]. Previous
studies have reported that the dynamic but independent
regulations of the NR2A and NR2B subunits by αCaMKII
and PSD-95, respectively, are modulated by competitive or
antagonistic interactions between these two scaffolding
proteins [10]. Furthermore, it has been shown that different
levels of NR2A and NR2B at synapses differentially regulate the
surface expression of glutamate receptor type 1 (GluR1)-
containing 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) pro-
panoic acid (AMPA) receptor via the Ras-activated extracellular
signal-regulated kinase (ERK) pathway, which is essential for
the modiﬁcation of synaptic strength [11].
AMPA receptor is an ionotropic glutamate receptor that
functions in fast synaptic transmission and plasticity [12].
At the excitatory synapses of central neurons, AMPA receptors
are organized into multiprotein signaling complexes within
the postsynaptic density [12]. In a previous study, it was
demonstrated that protein kinase G regulates AMPA receptor
trafﬁcking by modulating GluR1-ser845 phosphorylation in
hippocampal slices [13], and in another, it was shown that the
αCaMKII–mediated Ser831 phosphorylation of GluR1 is asso-
ciated with AMPA receptor expression and potentiation in the
postsynaptic membrane [14]. However, diminished αCaMKII
levels result in the detachment of GluR1 subunit-containing
AMPA receptors from cell surfaces and in the attenuation of
AMPA receptor currents [15].
Accordingly, alterations in the levels of postsynaptic pro-
teins in the hippocampus can signiﬁcantly affect cogni-
tive impairment through the synaptic dysfunction andsubsequent neuronal vulnerability, and thus could contribute
importantly to uremic encephalopathy in CRF. In this study,
changes in the protein expressions of postsynaptic proteins
and their interactions in the hippocampi of CRF rats were
examined.Methods
Experimental animals
Studies were performed using adult male SpragueDawley
rats weighing 29078 g. Animals were maintained on a standard
rodent diet with free access towater. The experimental procedures
used were reviewed and approved by the Animal Care and Use
Committee of Dongguk University, Gyeongju, Korea. Animal care
and use were also in accord with the guidelines issued by the
National Institute of Health (Bethesda, MD, USA).Induction of CRF by surgical reduction
Experimental CRF was induced by excising approximately
two-thirds of the left kidney and performing right total
nephrectomy [16]. The protocols used in this study are
depicted in Fig. 1. Rats were anesthetized with 3% isoﬂurane
in a mixture of oxygen/nitrous oxide (30:70) and maintained
on 1.5% isoﬂurane. During surgery, a heating pad was used to
maintain a rectal temperature of 37–381C. The left kidney was
exposed via a left ﬂank incision and gently dissected free from
the adrenal gland. Approximately two-thirds of the left kidney,
including the upper and lower poles, was then excised. One
week after initial surgery, again under isoﬂurane anesthesia,
right kidneys were excised (after release from the adrenal
gland) and removed through a right ﬂank incision. Some rats
were subjected to an identical sham operation, but kidneys
were left intact. Sham-operated rats and 5/6 nephrectomized
CRF rats were monitored for 7 weeks after surgery for estab-
lishing the long-term effects of chronic kidney disease on the
brain. Cornu ammonis (CA) 1 and CA3/ dentate gyrus (DG)
tissue sections of hippocampus were separated under the
surgical microscopy and then rapidly frozen at 801C until
required for protein assays.
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Twenty four-hour urine samples were collected in meta-
bolic cages on the last day of the experiment. Blood samples
were taken from abdominal aortas under isoﬂurane-
anesthesia and heparinized (10 IU/mL of blood). Plasma was
immediately separated by centrifugation (2,000  g for 3 min-
utes at 41C). Urine and plasma samples were stored in a freezer
(801C) until required for chemical analyses. Hematocrit,
plasma creatinine, and urinary creatinine clearance were
measured using conventional methods.
Cresyl violet staining
Sham-operated control rats (n¼3) and 5/6 nephrectomized
CRF rats (n¼3) were anesthetized and the brain was ﬁxed by a
transcardiac perfusion of 4% paraformaldehyde in phosphate
buffered saline (PBS) after removal of blood from the cerebral
vasculature by perfusion of physiologic saline. The brain was
removed and postﬁxed in the same ﬁxative for 12 hours.
Perfusion ﬁxed brain tissues were parafﬁn-embedded and
serial coronal sections (5 μm thickness) were obtained at the
level of dorsal third ventricle (bregma–4.16 mm). Parafﬁn wax
was removed by xylene overnight at room temperature and
the sections were rehydrated with ethanol (99%, 96%, and
70%). After washing in distilled water, the sections were
stained with cresyl violet for 30 minutes at room temperature.
The sections were then treated successively with ethanol (50%,
70%, 95%, and 100%) and differentiator (glacial acetic acid and
95% ethanol).
Hippocampal homogenate preparation
For protein extraction, each hippocampal CA1 and CA3/DG
subﬁeld tissue sections were homogenized in ice-cold homo-
genizing buffer [50mM HEPES, 50mM NaF, 20mM sodiumFigure 2. Neuronal cell death in the hippocampal CA1 subﬁeld after C
(A) Different subpopulations of hippocampal cells were chosen to characteri
subﬁeld in the hippocampus. (B, D, F) There were no necrotic cells in the
typical necrotic cell death. (E, G) In contrast, the cells in the CA3/dentate gyr
CRF n¼3. (H) Immunoblotting for neuronal nuclei (NeuN) protein revealed
used as an internal control to conﬁrm equal protein loading. (I) Imm
CA1 subﬁeld were signiﬁcantly decreased after CRF. In contrast, levels of
are means7SEMs. Control n¼8, CRF n¼8. *Po0.01. CA1, cornu ammonis 1pyrophosphate (NaPPi), 1mM EDTA, 8.5mM leupeptin, and
1mM phenylmethylsulfonyl ﬂuoride (PMSF); pH 7.4; n¼16:
sham operated control rats (n¼8) and CRF rats (n¼8)]. Protein
contents were measured using the Bio-Rad protein assay kit
(Bio-Rad Laboratories, Hercules, CA, USA).
Semiquantitative immunoblotting
The levels of proteins in hippocampal samples were deter-
mined by immunoblotting under conditions of protein linear-
ity. After sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), proteins were transferred to
nitrocellulose membranes in a buffer solution containing
50mM tris-base, 380mM glycine, and 20% methanol. Mem-
branes were then blocked with 5% milk in PBS-T (80mM
Na2HPO4, 20mM NaH2PO4, 100mM NaCl, 0.1% Tween 20; pH
7.5) for 1 hour and incubated overnight at 41C with mouse
antineuronal nuclei (NeuN; 1:1,000; Chemicon, Temecula, CA,
USA), rabbit antiPSD-95 (1:1,000), mouse anti-CaMKII
(1:2,000), or mouse anti-p-Ser831 and 845 GluR1 (1:1,000;
Santa Cruz Biotechnology, Texas, USA). Sites of antibody–
antigen reaction were visualized using horseradish peroxidase
(HRP)-conjugated secondary antibodies (P447 or P448, diluted
1:3,000; DAKO, Glostrup, Denmark) and an enhanced chemi-
luminescence system (ECL, Amersham Pharmacia Biotech,
Little Chalfont, UK), and then exposed to photographic ﬁlm
(Hyperﬁlm ECL, RPN3103K, Amersham Pharmacia Biotech).
Immunoblot signals developed using the ECL system were
quantiﬁed using Scion Image software (version 1.59; Bethesda,
Maryland, USA).
Immunoprecipitation
Hippocampal CA1 homogenates (600 μg) were diluted four-
fold with 50mM HEPES buffer (10% glycerol, 150mM NaCl, 0.5%
NP-40, 10mM Tris-HCl, 1.0mM EDTA, 1.0mM PMSF 1.0% TritonRF was determined by cresyl violet staining and immunoblotting.
ze the cellular changes under CRF (X4). Rectangle indicates the necrotic
sham-operated rat hippocampus. (C) Cells in the CA1 subﬁeld undergo
us region were more resistant to necrotic cell death (X20). Control n¼3,
a major strong band at 32 kDa in sham-operated controls. a-actin was
unoblotting analyses showed that the expressions of NeuN in the
NeuN in the CA3 and DG subﬁelds were unchanged after CRF. Results
; CA3, cornu ammonis 3; CRF, chronic renal failure; DG, dentate gyrus.
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puriﬁed rabbit antiPSD-95 (Upstate Biotechnology, Lake Placid
NY, USA) and αCaMKII antibodies (Afﬁnity Bioreagents, Golden
Colorado, USA; both 1:50) were added. After incubating mixtures
for 4 hours at 41C, protein A-agarose slurry (1:1) was added and
incubated for a further 2 hours. Samples were then centrifuged at
100,000 g and the pellets collected were washed three times
with HEPES buffer. Bound proteins were eluted by adding four
volumes of SDS gel electrophoresis sample buffer, and then
boiled for 7 minutes. Finally samples were centrifuged at
100,000  g for 2 minutes and the supernatants so obtained
were applied to SDS-gels and electrotransfered onto nitrocellu-
lose membrane for immunoblotting with anti-NR2A antibody or
anti-NR2B antibody (1: 1,000; Upstate Biotechnology, Lake Placid
NY, USA).Figure 3. Normalized expressions of postsynaptic density-95 (PSD-
95) and of a isoform of calcium/calmodulin-dependent protein
kinase II (aCaMKII) in rats hippocampi after CRF. (A) Immunoblot
with anti-PSD-95 and aCaMKII antibodies revealed 95 and 50 KDa
bands, respectively, in sham-operated and CRF rats. (B) In CA1
subﬁelds, densitometric analyses revealed that CRF signiﬁcantly
decreased PSD-95 expression but signiﬁcantly increased aCaMKIIData analysis
Values are presented as mean7standard error of mean
(SEM). Groups were compared using one-way analysis of
variance (ANOVA) followed by Bonferroni's post hoc test. The
statistical differences were considered signiﬁcant if the P
values less than 0.05 or 0.01.expression. The expressions of PSD-95 and aCaMKII after CRF were
unchanged in the CA3/DG subﬁelds. Results are means7SEMs.
Control n¼8, CRF n¼8. *Po0.01. CA1, cornu ammonis 1; CA3, cornu
ammonis 3; CRF, chronic renal failure; DG, dentate gyrus; SEM,
standard error of mean.Results
Establishment of CRF induced by 5/6 nephrectomy
Seven weeks after 5/6 nephrectomy, CRF rats lost 9% of
body weight as compared with the sham-operated controls.
Diminished renal function was demonstrated by signiﬁcant
increases in plasma creatinine levels (8.7570.47 in CRF vs.
1.1370.55 mg/dL in sham-operated controls; Po0.05) and
urine outputs (61.4710.9 in CRF vs. 45.973.1 mL/kg/d in
sham-operated controls; Po0.05). Urinary creatinine clear-
ance was also signiﬁcantly decreased (4.4570.32 in CRF vs.
7.3270.83 L/kg/d in sham-operated controls; Po0.05). In
addition, CRF rats had lower hematocrit levels (37.470.6 in
CRF vs. 42.370.6% in sham-operated controls; Po0.05).Figure 4. CRF induced changes in bindings between PSD-95 or
aCaMKII and NMDA receptor subunits (NR2A and NR2B) in the rat
hippocampal CA1 subﬁeld. (A) Homogenate samples from sham-oper-
ated and CRF rats were immunoprecipitated with anti-PSD-95 and anti-
aCaMKII antibodies, respectively. Immunoprecipitates were analyzed by
immunoblotting with anti-NR2A or anti-NR2B antibodies. (B) Quantitative
analysis of immunoblots showed the amount of NR2B that co-precipi-
tated with PSD-95 was lower, but that the amount of NR2A that co-
precipitated with aCaMKII was higher after CRF. Results are mean-
s7SEMs. Control n¼8, CRF n¼8. *Po0.01. CA1, cornu ammonis 1;
CRF, chronic renal failure; NMDA, N-methyl-D-aspartate; PSD-95,
postsynaptic density-95; αCaMKII, α isoform of calcium/calmodulin-
dependent protein kinase II; SEM, standard error of mean.Neuronal cell death in the CA1 subﬁeld of uremic hippocampi
Cresyl violet staining demonstrated that cells in the medial
CA1 subﬁeld of hippocampus (Fig. 2A, rectangle) underwent
typical necrotic cell changes, such as dark in color, irregular
shape, cork-screw processes, and expansion of perineuronal
space (Fig. 2C, arrows). By contrast, cells in the CA3 subﬁeld
and DG region were more resistant and less necrotic cell death
was observed (Fig. 2E and G). Semiquantitative immunoblot-
ting for neuronal nuclei (NeuN) protein revealed a major
strong band at 32 kDa in sham-operated controls (α-actin
was used as internal loading control; Fig. 2H). Immunoblotting
demonstrated that the expressions of NeuN in CA1 subﬁeld
homogenates were signiﬁcantly reduced by CRF (to 7276.3%
vs. sham-operated controls, n¼8, Po0.01). By contrast, levels
of NeuN in CA3 and DG subﬁelds were not changed by CRF
(Fig. 2I).
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hippocampi
It was examined whether levels of PSD-95 and αCaMKII
were altered in the CA1 and CA3/DG subﬁelds by CRF. Semi-
quantitative immunoblotting demonstrated that CRF induced
signiﬁcant changes in the levels of both proteins in the CA1
subﬁeld but not in the CA3/DG subﬁelds. In the hippocampi of
sham-operated control rats and CRF rats, immunoblotting for
PSD-95 and αCaMKII revealed major strong bands at 95 kDa
and 50 kDa, respectively (Fig. 3A). In the CA1 subﬁeld, PSD-95
expression was signiﬁcantly lower in CRF rats than in sham-
operated controls (to 7774.7% of sham-operated controls,
Po0.01, n¼8). By contrast, αCaMKII expression in the CA1
subﬁeld was signiﬁcantly higher in CRF rats (to 157710.3% of
sham-operated controls, Po0.01, n¼8, Fig. 3B). Immunoblot
analysis of the CA3/DG subﬁelds did not reveal any changes in
the expressions of PSD-95 or αCaMKII (Fig. 3A and B). α-Actin
was used as internal control to conﬁrm equal protein loadings.Bindings between the PSD-95/αCaMKII and the subunits of
NMDA receptors in the CA1 subﬁeld of uremic hippocampus
Because the regulatory subunits (NR2A and NR2B) of NMDA
receptors dynamically bind to αCaMKII [17] and PSD-95 [10],
respectively, changes in the expressions of PSD-95 and αCaMKII
raised the possibility that synaptic complexes between the PSD-
95/αCaMKII and the regulatory subunits (NR2B and NR2A,
respectively) of NMDA receptors were disrupted by CRF. As
indicated in Fig. 4A, the amount of NR2B that coprecipitated
with PSD-95 was lower in CRF rats (to 7271.7% of that of sham-
operated controls, Po0.01, n¼8; Fig. 4B). However, no change in
the amount of NR2A that coprecipitated PSD-95 was detected
after CRF. Protein homogenates were also immunoprecipitatedFigure 5. Determination of the phosphorylations of GluR1 at ser831
or ser845 in the hippocampal CA1 subﬁeld after CRF. (A) Samples of
sham-operated control and CRF CA1 tissues were immunoblotted with
anti-GluR1-ser831 or anti-GluR1-ser845. Immunoblotting for GluR1-
ser831 and GluR1-ser845 revealed major strong bands at 132 kDa and
100 kDa, respectively. (B) Densitometric analyses revealed that CRF
signiﬁcantly increased in p-GluR1 (ser831), but not p-GluR1 (ser845), in
the CA1 subﬁeld. Results are means7SEMs. Control n¼8, CRF n¼8.
*Po0.01. CA1, cornu ammonis 1; CRF, chronic renal failure; GluR1,
glutamate receptor type 1; SEM, standard error of mean.with anti-αCaMKII (Fig. 4A), and it was found that binding
between αCaMKII and NR2A was signiﬁcantly enhanced by CRF
(to 15070.9% of that of sham-operated controls, Po0.01, n¼8;
Fig. 4B). However, no signiﬁcant changes were observed in the
amount of αCaMKII that coprecipitated with NR2B after CRF.
Phosphorylations of GluR1 at ser831 and ser845
in the CA1 subﬁeld
To determine whether CRF induces the phosphorylations of
GluR1-ser831 and GluR1-ser845 in the uremic CA1 subﬁeld,
samples of sham-operated control and CRF CA1 tissues were
immunoblotted with antiGluR1-ser831 and antiGluR1-ser845.
In sham-operated control rats and CRF rats, immunoblotting
for GluR1-ser831 and GluR1-ser845 revealed major strong
bands at 132 kDa and 100 kDa, respectively (Fig. 5A). Further-
more, the expression of GluR1-ser831 in the uremic CA1
subﬁeld was higher than in sham-operated controls (1297
3.5% of sham-operated controls, Po0.01, n¼8). However, the
expression of GluR1-ser845 showed no signiﬁcant change
(Fig. 5B).Discussion
Several studies have suggested that the frequency of cog-
nitive disturbance is higher than that previously suspected and
can be detected even in moderate chronic renal insufﬁciency
[4,18]. In the present study, CRF was induced in rats by 5/6
nephrectomy and animals were then monitored for 7 weeks. In
2013, Fujisaki et al [19] followed rats for 4 weeks or 8 weeks to
establish the long-term effects of uremia and found that serum
creatinine and blood urea nitrogen concentrations in 5/6
nephrectomy mice were signiﬁcantly higher than in control
mice. However, they reported that no signiﬁcant difference in
all parameters between CKD-4W and CKD-8W. Hence, we
have chosen the duration of follow-up to 7 weeks after
surgery.
Uremia induced by CRF in the present study produced
necrotic cell death and decreased neuronal marker protein
(NueN) levels in the hippocampal CA1 subﬁeld, but not in the
CA3/DG subﬁelds, indicating that CA1 is more vulnerable to
neuronal cell death in CRF than CA3/DG. This proposition is
generally in accord with observations of ischemic injury-
induced changes in postsynaptic density, during which CA1
neurons are more prone to injury than CA3 or DG neurons
[20]. Kesner et al [21] emphasized that CA1 subﬁeld involved
in spatial working memory in pattern separation, with CA3
subﬁeld being more important in spatial working memory in
pattern completion and in pattern association. Compromised
renal function was found to present model CRF, in terms of
increased plasma creatinine levels and decreased creatinine
clearance. Similar to guanidine, guanidinosuccinic acid, and
methylguanidine, creatinine is a guanidine compound and is
thus considered a candidate uremic toxin. During uremia, the
accumulation of neurotoxic metabolites may be important in
the pathogenesis of uremic encephalopathy [22,23]. Brain
guanidinosuccinic acid and creatinine concentrations, corre-
sponding with intraperitoneal doses that induce clonic con-
vulsions in mice, are similar to the concentrations found in the
brains of uremic patients [23]. Therefore, increased levels of
creatinine in plasma is a candidate factor responsible for the
cell death of hippocampal CA1 subﬁeld which may be closely
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pattern separation. These toxins have been reported to
increase the activation of NMDA receptors and to block GABAA
receptor ionophores [3]. The activation of NMDA receptors
elicits Ca2þ inﬂux, potentially causing calcium-mediated neu-
rotoxicity. Immunoprecipitation and immunoblotting in the
present study demonstrated that CRF was associated with
signiﬁcant changes in the expressions of postsynaptic protein
complexes. First, a selective decrease in the expression of PSD-
95/NR2B synaptic complex in the uremic CA1 subﬁeld was
found. Wang et al [24] showed that PDZ1 domain of PSD-95
protects neurons from cerebral ischemia. However, in a rat
model, preconditioning ischemia was found to attenuate
transient hippocampal ischemic damage by inducing an
increase of PSD-95 [25]. In addition, previous studies have
shown that upregulation of NR2A and NR2B after chronic
ethanol exposure is likely to be an adaptive response to
prolonged inhibition of channel activity by ethanol because
of no corresponding change in the amount of PSD-95 [26,27].
Therefore, PSD-95 downregulation by CRF may reduce the
targeting of NR2B to synapses and may be related to the
synaptic dysfunction. Secondly, it was found that NR2A/αCaM-
KII synaptic complex was upregulated in the uremic CA1
subﬁeld. αCaMKII, which is essential for memory and learning
acquisition, abundantly expressed in the hippocampus and is
known to be involved in the regulation of the functional
subunit composition of NMDA receptors in the postsynaptic
zone [28,29]. Moreover, the regulation of αCaMKII is depen-
dent on many factors, including PSD-95 [30]. Previous studies
have suggested that NR2A is a key NMDA receptor subunit
with respect to the modulation of αCaMKII binding to NMDA
channel [23,24]. The upregulation of αCaMKII in the CA1
subﬁeld suggests that NR2A-containing NMDA receptors may
be increased in the synapse after CRF. Thus, our results suggest
that activation of NMDA receptor resulted from CRF is closely
associated with an alteration of the NR2 subunits of NMDA
receptors at synapses.
Recently, Kim et al [31] reported that NMDA receptor activation
has differential effects on the surface delivery of GluR1, and that
these effects depend on the NR2A/NR2B subunit ratios of NMDA
receptors at synapses. In the hippocampus, AMPA receptors are
mainly composed of GluR1/GluR2 or GluR2/GluR3 dimers with a
minority of GluR1 homomers [32]. Recently, it was demonstrated
that the surface expression of GluR1 in mature neurons is
supported by NR2A-containing NMDA receptors, but inhibited
by NR2B-containing NMDA receptors [33]. Other studies have also
indicated that in mature neurons, NR2B is associated with the
inhibition of (rather than the activation of) the Ras-ERK signaling
pathway, which drives GluR1 to synapses [31,34]. Thus, our results
suggest that increases in NR2A-containing NMDA receptors after
CRF induce Ras-ERK pathway activation and subsequent increase
GluRl delivery to synapses.
In a recent study, it was implied that the ser831 phosphor-
ylation of GluR1 might partly underlie synaptic modiﬁcation
[35]. Furthermore, accumulating evidence suggests that GluR1
phosphorylation at ser831 is closely related to αCaMKII/NR2A
synaptic complex during long-term potentiation (LTP) [36].
αCaMKII translocated to the postsynaptic density, formed
sites to anchor GluR1, and phosphorylated GluR1 after being
activated by Ca2þ inﬂux through NMDA receptor during LTP
[36]. Thus, the observed increase in GluR1-ser831 phosphor-
ylation, but not in GluR1-ser845 phosphorylation, in the ure-
mic CA1 subﬁeld suggests that activated αCaMKII translocatedto the synaptic membranes and then activated GluR1-
containing AMPA receptors via GluR1-ser831 phosphorylation.
Furthermore, as elevated levels of activated GluR1-containing
AMPA receptors directly affect Naþ and Ca2þ inﬂux, and
hence, increased Naþ and Ca2þ inﬂuxes through activated
GluR1-containing AMPA receptors may play a role in the
neuronal vulnerability of the CA1 subﬁeld. Our results suggest
that the activation of GluR1-containing AMPA receptors at
synapses, caused by the upregulation of αCaMKII/NR2A synap-
tic complex, is directly responsible for neurotoxicity in CA1
neurons rather than NMDA-induced neurotoxicity.
Taken together, our ﬁndings show that uremia after
CRF can induce neuronal cell death of hippocampal CA1
subﬁeld which may result in cognitive impairment in the
uremic rat brain. Upregulation of αCaMKII/NR2A synaptic
complex and subsequent augmentation of the phosphory-
lated GluR1-containing AMPA receptor at synapses can be
suggested as the hypothetical mechanism of hippocampal
CA1 cell death.Conﬂict of interest
The authors declare no conﬂict of interest.
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